Rega Institute (IMAGE)
Caption
AstriVax will draw on technology developed at the KU Leuven Rega Institute to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.
Credit
KU Leuven - Rob Stevens
Usage Restrictions
This image may only be used with appropriate credit and caption.
License
Original content